BPC-157 route of administration BPC-157 can be taken orally or it can be injected subcutaneously (just beneath the skin)
TB-500 was administered both topically (5-50 g per wound for dermal injuries
This information does not take the place of talking to your healthcare provider about your medical condition or your treatment
The most common causes include B12 supplementation (particularly injections), liver disease releasing stored B12, haematological disorders increasing B12-binding proteins, and chronic kidney disease reducing B12 excretion
Monitoring is recommended for patients with liver diseases, as well as those who consume excessive alcohol
BPC-157 injections may be discussed for people focused on tendons, joints, ligaments, muscles, or broader tissue recovery